CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
MagStimdevice
Likely dose
1 Hz repetitive stimulation to right frontal areaAI-extracted
Key inclusion· 3
  • ✓DSM-IV Bipolar I or II Disorder with current major depressive episode
  • ✓Prior failure to respond to or tolerate at least 2 adequate pharmacotherapy trials
  • ✓Ham-D score ≥18
Key exclusion· 12
  • ✕Any psychotic disorder (lifetime), including schizoaffective disorder or major depression with psychotic features
  • ✕History of seizure except those therapeutically induced by ECT
  • ✕Lifetime treatment with more than 12 antidepressant medication trials
  • ✕ECT treatment within 3 months prior to screening

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00186485
NCT00186485N/ACompleted
CompareCT.gov

Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression

Stanford University·interventional·Posted Sep 16, 2005·Updated Oct 6, 2017

In Brief

A clinical study evaluating MagStim for Bipolar Disorder. Completed, enrolled 28 participants across 1 site.

Detailed Summary

We hope to learn whether this stimulation of neurons in the front part of the brain may relieve depression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartMay 1, 2003
Primary CompletionJun 1, 2010
Study CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 20.8 years ago

Interventions

MagStimdevice

The MagStim delivers low frequency 1Hz stimulation to the right frontal area of the brain